Sharon M. Watling
2013
In 2013, Sharon M. Watling earned a total compensation of $265.1K as Former Vice President Clinical Development at Vericel, a 42% decrease compared to previous year.
Compensation breakdown
| Salary | $79,811 |
|---|---|
| Other | $185,299 |
| Total | $265,110 |
Watling received $185.3K in other compensation, accounting for 70% of the total pay in 2013.
Watling also received $79.8K in salary.
Rankings
In 2013, Sharon M. Watling's compensation ranked 11,100th out of 12,286 executives tracked by ExecPay. In other words, Watling earned more than 9.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,100 out of 12,286 | 10th |
Division Manufacturing | 4,164 out of 4,612 | 10th |
Major group Chemicals And Allied Products | 1,318 out of 1,462 | 10th |
Industry group Drugs | 1,044 out of 1,156 | 10th |
Industry Biological Products, Except Diagnostic Substances | 175 out of 196 | 11th |
Source: SEC filing on October 21, 2014.
Watling's colleagues
We found five more compensation records of executives who worked with Sharon M. Watling at Vericel in 2013.